1. Application of an electrochemiluminescence assay for quantification of E6011, an anti-fractalkine monoclonal antibody, to pharmacokinetic studies in monkeys and humans;Aoyama;Journal of Clinical Laboratory Analysis,2019
2. Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans;Bugelski;Current Opinion in Molecular Therapeutics,2004
3. Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys;Choi;Journal of Pharmaceutical and Biomedical Analysis,2016
4. Method validation of a bridging immunoassay in combination with acid-dissociation and bead treatment for detection of anti-drug antibody;Du;Heliyon,2023
5. Role of anti-fractalkine antibody in suppression of joint destruction by inhibiting migration of osteoclast precursors to the synovium in experimental arthritis;Hoshino-Negishi;Arthritis & Rhematology,2019